{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:31:47Z","timestamp":1785321107804,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.critrevonc.2022.103868","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:38:26Z","timestamp":1669214306000},"page":"103868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["International consensus on the initial diagnostic workup of cancer of unknown primary"],"prefix":"10.1016","volume":"181","author":[{"given":"Iris","family":"van der Strate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Kazemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris D.","family":"Nagtegaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Robbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"van de Wouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina S.","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Duijts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Anthony","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Qaseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petur","family":"Snaebjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie Veldhuijzen","family":"van Zanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Loef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2022.103868_bib1","unstructured":"Anon, n.d. \u3008https:\/\/www.england.nhs.uk\/midlands\/wp-content\/uploads\/sites\/46\/2019\/05\/investigation-diagnosis-mgmnt-mou-and-cup-v2.pdf\u3009."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103868_bib2","first-page":"91","article-title":"Multi-tier system of supports (MTSS)","volume":"48","author":"Averill","year":"2011","journal-title":"Dist. Adm."},{"key":"10.1016\/j.critrevonc.2022.103868_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00002","article-title":"Mutational signature and transcriptomic classification analyses as the decisive diagnostic tools for a cancer of unknown primary","volume":"2","author":"Bagge","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103868_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/1176935119872163","article-title":"Hierarchical classification of cancers of unknown primary using multi-omics data","volume":"18","author":"Bavafaye Haghighi","year":"2019","journal-title":"Cancer Inform."},{"key":"10.1016\/j.critrevonc.2022.103868_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103208","article-title":"Melanoma of unknown primary: New perspectives for an old story","volume":"158","author":"Boussios","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103868_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1148\/rg.305095764","article-title":"FDG PET with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma","volume":"30","author":"Chu","year":"2010","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103868_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-020-01154-3","article-title":"Culturally responsive approaches for addressing ADHD within multi-tiered systems of support","volume":"22","author":"Dong","year":"2020","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.critrevonc.2022.103868_bib8","unstructured":"Ettinger, D.S., et al., NCCN Clinical Practice Guidelines in Oncology: Occult Primary. National Comprehensive Cancer Network, version 1, 2021."},{"key":"10.1016\/j.critrevonc.2022.103868_bib9","unstructured":"Excellence, N.I.f.C., Metastatic malignant disease of unknown primary origin in adults: diagnosis and management. NICE Guideline (CG104), 2010."},{"issue":"Suppl 5","key":"10.1016\/j.critrevonc.2022.103868_bib10","doi-asserted-by":"crossref","first-page":"v133","DOI":"10.1093\/annonc\/mdv305","article-title":"Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Fizazi","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103868_bib11","doi-asserted-by":"crossref","first-page":"v133","DOI":"10.1093\/annonc\/mdv305","article-title":"Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Fizazi","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103868_bib12","doi-asserted-by":"crossref","unstructured":"Haddad, T.S., et al., Improving tumor budding reporting in colorectal cancer: a Delphi consensus study. Virchows Arch, 2021.","DOI":"10.1007\/s00428-021-03059-9"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103868_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-022-01667-w","article-title":"Methodology for the development of National Multidisciplinary Management Recommendations using a multi-stage meta-consensus initiative","volume":"22","author":"Hardman","year":"2022","journal-title":"BMC Med. Res. Methodol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103868_bib14","first-page":"3403","article-title":"Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma","volume":"5","author":"Hess","year":"1999","journal-title":"Clin. Cancer Res"},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103868_bib15","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/ACM.0000000000001812","article-title":"The use of the Delphi and other consensus group methods in medical education research: a review","volume":"92","author":"Humphrey-Murto","year":"2017","journal-title":"Acad. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103868_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ACM.0000000000002887","article-title":"The Delphi method","volume":"95","author":"Humphrey-Murto","year":"2020","journal-title":"Acad. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103868_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13825-8","article-title":"A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns","volume":"11","author":"Jiao","year":"2020","journal-title":"Nat. Commun."},{"issue":"7001","key":"10.1016\/j.critrevonc.2022.103868_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103868_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-02543-1","article-title":"Real-world data analysis of patients with cancer of unknown primary","volume":"11","author":"Kang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2022.103868_bib20","article-title":"International variation in diagnostic and treatment guidelines for carcinoma unknown primary","volume":"1","author":"Kok","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103868_bib21","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3389\/fonc.2019.01546","article-title":"\u201cMetastatic Cancer of Unknown Primary\" or \"Primary Metastatic Cancer\u201d?","volume":"9","author":"Kolling","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2022.103868_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00171","article-title":"Validating comprehensive next-generation sequencing results for precision oncology: the NCT\/DKTK molecularly aided stratification for tumor eradication research experience","volume":"2","author":"Lier","year":"2018","journal-title":"JCO Precis. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103868_bib23","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s12094-018-1899-z","article-title":"Consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary","volume":"20","author":"Losa","year":"2018","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103868_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12094-017-1807-y","article-title":"SEOM clinical guideline on unknown primary cancer (2017)","volume":"20","author":"Losa","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103868_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00122","article-title":"Rationale and design of the targeted agent and profiling utilization registry study","volume":"2","author":"Mangat","year":"2018","journal-title":"JCO Precis. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103868_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrclinonc.2011.158","article-title":"Carcinomas of an unknown primary origin--diagnosis and treatment","volume":"8","author":"Massard","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103868_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrclinonc.2017.97","article-title":"Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary","volume":"14","author":"Moran","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103868_bib28","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1186\/s12889-020-09814-y","article-title":"Establishing consensus on key public health indicators for the monitoring and evaluating childhood obesity interventions: a Delphi panel study","volume":"20","author":"O'Donnell","year":"2020","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103868_bib29","doi-asserted-by":"crossref","first-page":"e769","DOI":"10.1002\/onco.13744","article-title":"A challenging task: identifying patients with cancer of unknown primary (CUP) according to ESMO guidelines: the CUPISCO trial experience","volume":"26","author":"Pauli","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2022.103868_bib30","first-page":"271","article-title":"Carcinoma of unknown primary (CUP)","volume":"69","author":"Pavlidis","year":"2009"},{"issue":"9824","key":"10.1016\/j.critrevonc.2022.103868_bib31","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","article-title":"Cancer of unknown primary site","volume":"379","author":"Pavlidis","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103868_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12094-007-0084-6","article-title":"Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables","volume":"9","author":"Ponce Lorenzo","year":"2007","journal-title":"Clin. Transl. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.critrevonc.2022.103868_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/jocn.15096","article-title":"Prostate cancer survivorship priorities for men and their partners: Delphi consensus from a nurse specialist cohort","volume":"29","author":"Ralph","year":"2020","journal-title":"J. Clin. Nurs."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103868_bib34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s12032-013-0706-5","article-title":"Unfavorable cancers of unknown primaries: presentation and prognostic factors. A population-based 8-year experience","volume":"30","author":"Randen","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103868_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canep.2019.06.006","article-title":"The currently declining incidence of cancer of unknown primary","volume":"61","author":"Rassy","year":"2019","journal-title":"Cancer Epidemiol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103868_bib36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2020.1807948","article-title":"The diagnostic challenges of patients with carcinoma of unknown primary","volume":"20","author":"Rassy","year":"2020","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.critrevonc.2022.103868_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2018.06.032","article-title":"Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012","volume":"101","author":"Schroten-Loef","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103868_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/apt.12347","article-title":"Natural history of acute upper GI bleeding due to tumours: short\u2010term success and long\u2010term recurrence with or without endoscopic therapy","volume":"38","author":"Sheibani","year":"2013","journal-title":"Aliment. Pharmacol. Therap."},{"key":"10.1016\/j.critrevonc.2022.103868_bib39","first-page":"1","article-title":"Expert consensus and perspectives on recovery following road traffic crashes: a Delphi study","author":"Smits","year":"2020","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.critrevonc.2022.103868_bib40","unstructured":"Specialists, Fo.M., Primaire tumor onbekend. Dutch Guidelines Database, 2012."},{"key":"10.1016\/j.critrevonc.2022.103868_bib41","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103868_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/wjnm.WJNM_62_17","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography in carcinoma of unknown primary: A subgroup-specific analysis based on clinical presentation","volume":"17","author":"Thapa","year":"2018","journal-title":"World J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103868_bib43","doi-asserted-by":"crossref","DOI":"10.15403\/jgld.2014.1121.261.haz","article-title":"How to diagnose and treat a cancer of unknown primary site","volume":"26","author":"Tomuleasa","year":"2017","journal-title":"J. Gastrointest. Liver Dis."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103868_bib44","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/bjc.2013.386","article-title":"Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities","volume":"109","author":"Urban","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103868_bib45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/106342669600400401","article-title":"Integrated approaches to preventing antisocial behavior patterns among school-age children and youth","volume":"4","author":"Walker","year":"1996","journal-title":"J. Emot. Behav. Disord."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103868_bib46","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103868_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0959-8049(01)00378-1","article-title":"Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992","volume":"38","author":"van de Wouw","year":"2002","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103868_bib48","first-page":"57","article-title":"An experimental study of the Delphi technique","volume":"5","author":"Young","year":"1978","journal-title":"Educ. Res. Perspect."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103868_bib49","first-page":"184","article-title":"Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach","volume":"17","author":"De Young","year":"2000","journal-title":"Semin. Diagn. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103868_bib50","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.3892\/ol.2016.5203","article-title":"Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography\/computed tomography in carcinoma of unknown primary","volume":"12","author":"Yu","year":"2016","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103868_bib51","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.3892\/ol.2016.5203","article-title":"Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography\/computed tomography in carcinoma of unknown primary","volume":"12","author":"Yu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2022.103868_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103030","article-title":"CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence","volume":"61","author":"Zhao","year":"2020","journal-title":"EBioMedicine"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282200292X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282200292X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:44:59Z","timestamp":1760903099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282200292X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":52,"alternative-id":["S104084282200292X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103868","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International consensus on the initial diagnostic workup of cancer of unknown primary","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103868"}}